Raha M, Wang G, Seidman M M, Glazer P M
Department of Therepeutic Radiology, Yale University School of Medicine, New Haven CT 06520-8040,USA.
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2941-6. doi: 10.1073/pnas.93.7.2941.
Psoralen-conjugated triple-helix-forming oligonucleotides have been used to generate site-specific mutations within mammalian cells. To investigate factors influencing the efficiency of oligonucleotide-mediated gene targeting, the processing of third-strand-directed psoralen adducts was compared in normal and repair-deficient human cells. An unusually high mutation frequency and an altered mutation pattern were seen in xeroderma pigmentosum variant (XPV) cells compared with normal, xeroderma pigmentosum group A (XPA), and Fanconi anemia cells. In XPV, targeted mutations were produced in the supF reporter gene carried in a simian virus 40 vector at a frequency of 30%, 3-fold above that in normal or Fanconi anemia cells and 6-fold above that in XPA. The mutations generated by targeted psoralen crosslinks and monoadducts in the XPV cells formed a pattern distinct from that in the other three cell lines, with mutations occurring not just at the damaged site but also at adjacent base pairs. Hence, the XPV cells may have an abnormality in trans-lesion bypass synthesis during repair and/or replication, implicating a DNA polymerase or an accessory factor as a basis of the defect in XPV. These results may help to elucidate the repair deficiency in XPV, and they raise the possibility that genetic manipulation via triplex-targeted mutagenesis may be enhanced by modulation of the XPV-associated activity in normal cells.
补骨脂素缀合的三链形成寡核苷酸已被用于在哺乳动物细胞内产生位点特异性突变。为了研究影响寡核苷酸介导的基因靶向效率的因素,在正常和修复缺陷的人类细胞中比较了第三链定向补骨脂素加合物的加工过程。与正常、A型着色性干皮病(XPA)和范可尼贫血细胞相比,在着色性干皮病变异型(XPV)细胞中观察到异常高的突变频率和改变的突变模式。在XPV中,在猴病毒40载体携带的supF报告基因中产生靶向突变的频率为30%,比正常或范可尼贫血细胞高3倍,比XPA高6倍。XPV细胞中靶向补骨脂素交联和单加合物产生的突变形成了一种与其他三种细胞系不同的模式,突变不仅发生在损伤位点,也发生在相邻的碱基对处。因此,XPV细胞在修复和/或复制过程中的跨损伤旁路合成可能存在异常,这意味着DNA聚合酶或辅助因子是XPV缺陷的基础。这些结果可能有助于阐明XPV中的修复缺陷,并且它们增加了通过调节正常细胞中与XPV相关的活性来增强三链靶向诱变的基因操作的可能性。